The problem to be addressed involves a well documented concern in the field of intravenous therapy and invasive hemodynamic monitoring. Fluid filled catheters while infusing fluids into the blood vessels can carry bacteria into a patient's blood leading to nosocomial bacteremias. The part of the problem this project deals with is stopcock contamination. The stopcock is a three-way valve device in the fluid line. The external port on the stopcock is used to gain temporary access to the fluid in the tubing. This project's long-term objective is to assess the feasibility of a product that may decrease bacteremias in those patients with invasive fluid lines where stopcocks are used. The method of resolving the issue involves the development and testing of a specialized cap for the stopcock. The cap is called a SNAP CAP.
The aim i nvolves completing the development of SNAP CAP prototypes and doing a pilot study with bacteriological testing to assess the feasibility of continued testing at multiple hospital sites. Challenges will be: developing a single cavity prototype mold that will be used to make a part consistent with the patented design, and completing the pilot bacteriological study.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43AI031739-01
Application #
3489508
Study Section
Special Emphasis Panel (SSS (B4))
Project Start
1991-09-30
Project End
1992-03-31
Budget Start
1991-09-30
Budget End
1992-03-31
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Gibson Enterprises of North America
Department
Type
DUNS #
City
Topeka
State
KS
Country
United States
Zip Code
66617